PCV24 A Threshold Analysis of the Cost-Effectiveness of Adjunctive Inclisiran Therapy for Ascvd Patients with LDL ≥70 MG/DL on Maximally Tolerated Statin Therapy
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.364
https://www.valueinhealthjournal.com/article/S1098-3015(21)00581-7/fulltext
Title :
PCV24 A Threshold Analysis of the Cost-Effectiveness of Adjunctive Inclisiran Therapy for Ascvd Patients with LDL ≥70 MG/DL on Maximally Tolerated Statin Therapy
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)00581-7&doi=10.1016/j.jval.2021.04.364
First page :
Section Title :
Open access? :
No
Section Order :
10939